The congenital dyserythropoietic anemias (CDA) comprise a group of very rare hereditary disorders, characterized by ineffective erythropoiesis and by distinct morphological abnormalities of the erythroblasts in the bone marrow. The classification proposed in 1968 (1) is still used today (2, 3) .
Morphological analysis is the first step in the diagnosis of all types of congenital dyserythropoietic anemia, to be followed by confirmatory tests. The morphological hallmarks of the erythroblasts, are not per se specific, but may also be observed as single abnormalities in other disorders of erythropoiesis. We therefore attempted to evaluate the quantity of the characteristic morphological abnormalities in patients with CDAI and CDA II.
Smears of peripheral blood and aspirated bone marrow were obtained from the German Registry on Congenital Dyserythropoietic Anemias. All specimens were originally used for diagnostic purposes. Patients were asked for informed consent for their use for scientific research, in agreement with the decision of the ethical committee of the University of Ulm. All patients were analyzed using a unique patient's number (CDA-UPN) that does not permit recourse of identifying data.
Specimens were stained by May-Grünwald -Giemsa stain. Thousand cells were examined for abnormalities. Occurrence of basophilic stippled cells or nucleated erythrocytes in the peripheral blood was listed but not quantified.
The relative fraction of erythroblasts was expressed as the ratio of erythroblasts to granulopoietic cells. Macrophages were examined for birefringence under polarized light.
The Mann-Whitney -U-test was used to compare cases and controls.
The diagnosis was based on parameters previously described before (4, 5) .
Confirmation of the diagnosis of CDA I required a mutation of the CDAN1-gene and/ or typical aberrations seen by electron microscopy (2, 6) . Confirmation of the diagnosis of CDA II required a mutation of the SEC23B-gene or at least one of the following parameters: A positive acid serum lysis test with ABO-compatible sera (7), a typical abnormality of band 3 shown by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (8, 9) , or a discontinuous double membrane in mature erythroblasts seen by electron microscopy (2) . Specimens of 19 (5 males, 14 females) and 36 patients (21 males, 15 females) with CDAI and CDA II, respectively, were available. Controls: Specimens of ten patients with distinct erythroid hyperplasia were selected as controls (six with hemolytic anemia, two with myeloid dysplastic syndromes, one with thalassemia intermedia, and one with bleeding and iron deficiency).
The peripheral blood showed distinct anisopoikilocytosis in all cases, with grade two (25 -50 % poikilocytes) in 19 (34%), and grade three(> 50%) in 36 (66%) of patients.
There was no difference between type I and II (p = 0.34). A few mature erythroblasts were seen in specimens of 31 and basophilic stippled red cells of 36 cases. These changes are highly sensitive, but in no way specific. All types of poikilocytes such as ovalocytes, microspherocytes, tear drop cells or irregularly contracted cells are seen.
In CDA I, large irregularly shaped macrocytes are seen and may suggest megaloblastic disease. The variegated appearance as described permits the exclusion of hereditary spherocytosis, an erroneous diagnosis that was often made before the diagnosis of CDA I or II was recognized (4, 5) . Mature erythroblasts may also be found in other types of severe anemia, but rarely in moderate anemias with a hemoglobin concentration of 90 -110 g/l characteristic for most patients with CDA (2, (10) or a variety of red cell disorders with erythroid hyperplasia. If more than 10% of typical binucleated erythroblasts are seen, together with more than 2 % cells with karyorrhexis, the diagnosis of CDA II is almost confirmed, and confirmatory tests such as sequencing the SEC23B gene are indicated. Pseudo-Gaucher macrophages containing birefringent needles found in the majority of cases, but in contrast to previous believe do not permit the differential diagnosis as compared with CDA I..
In conclusion, the diagnosis CDA I and CDA II can be made with high reliability from diligent analysis of peripheral blood and technically appropriate specimens of aspirated bone marrow. However, the results of this study clearly demonstrate that their specificity for the diagnosis of CDA relies not on their presence, but rather on the mosaic of morphological aberrations and the frequency of their occurrence.
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